ArticleOPEN ACCESS

Cancer-targeting antibody–drug conjugates drive dealmaking frenzy

Nature Biotechnology
DOI: 10.1038/s41587-024-02168-5
24Citations
Citations of this article
41Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Improved linker technologies and broadening payload options mark a coming of age for these precision cancer therapies.

Cite

CITATION STYLE

APA

Senior, M. (2024, March 1). Cancer-targeting antibody–drug conjugates drive dealmaking frenzy. Nature Biotechnology. Nature Research. https://doi.org/10.1038/s41587-024-02168-5

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free